Proton radiation study for children with neuroblastoma
Part of Cancer clinical trials.
This trial tests proton radiation therapy in children and young adults with neuroblastoma (a cancer of nerve tissue). It aims to see how well this focused type of radiation works, including whether it can be given even when there isn’t a measurable tumor at the time of treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have neuroblastoma or ganglioneuroblastoma, or (if no tumor tissue) higher abnormal urine catecholamine levels
- Your age at diagnosis is 3 to 25 years
- You’re expected to live more than 12 months
- You can take part in daily activities fairly well (performance status not worse than 2)
- You can get recent scans (MRI/CT) of the treatment area within 8 weeks, plus required baseline bone marrow and bone imaging
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether adding either a targeted drug (lorlatinib) or a radioactive treatment (131I-MIBG) to intensive chemotherapy improves outcomes for children with high-risk neuroblastoma. It may help by aiming at tumor cells more directly alongside standard treatment.
This trial tests a combination of a radioactive drug (MIBG) that targets neuroblastoma cells, with two other drugs that may help the radiation work better. It is for children and young adults with high-risk neuroblastoma that has come back or not gone away after standard treatment.
This trial uses a special PET scan called 18F-mFBG to take pictures of neuroblastoma tumors. It helps doctors see where the cancer is and whether treatment is working.
This trial tests a combination of chemotherapy and immunotherapy as a first treatment for children and young adults with high-risk neuroblastoma. The goal is to see if this approach can improve outcomes.
This study is for children or young adults already in specific brain tumor or neuroblastoma trials. It looks at how a type of imaging (MCT) might help doctors better understand and treat these cancers.
This Phase 3 trial tests treatments for children and teens with high-risk neuroblastoma, aiming to improve outcomes by using biology-based risk information. It also requires limited prior chemotherapy and specific timing after diagnosis.
Hear when a new Neuroblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.